GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Yidu Tech Inc (HKSE:02158) » Definitions » Retained Earnings

Yidu Tech (HKSE:02158) Retained Earnings : HK$-9,591.9 Mil (As of Sep. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Yidu Tech Retained Earnings?

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. Yidu Tech's retained earnings for the quarter that ended in Sep. 2023 was HK$-9,591.9 Mil.

Yidu Tech's quarterly retained earnings declined from Sep. 2022 (HK$-9,607.3 Mil) to Mar. 2023 (HK$-10,098.3 Mil) but then increased from Mar. 2023 (HK$-10,098.3 Mil) to Sep. 2023 (HK$-9,591.9 Mil).

Yidu Tech's annual retained earnings declined from Mar. 2021 (HK$-8,915.8 Mil) to Mar. 2022 (HK$-10,157.4 Mil) but then increased from Mar. 2022 (HK$-10,157.4 Mil) to Mar. 2023 (HK$-10,098.3 Mil).


Yidu Tech Retained Earnings Historical Data

The historical data trend for Yidu Tech's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Yidu Tech Retained Earnings Chart

Yidu Tech Annual Data
Trend Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Retained Earnings
Get a 7-Day Free Trial -2,621.34 -4,149.28 -8,915.79 -10,157.40 -10,098.35

Yidu Tech Semi-Annual Data
Mar18 Mar19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Retained Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only -9,540.44 -10,157.40 -9,607.33 -10,098.35 -9,591.91

Yidu Tech Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.


Yidu Tech  (HKSE:02158) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.


Yidu Tech (HKSE:02158) Business Description

Traded in Other Exchanges
Address
No.9 Building of Huayuan North Road, 8th Floor Health Work, Haidian District, Beijing, CHN
Yidu Tech offers healthcare Big Data. It is an AI cloud-based firm providing solutions and tools to aid in more informed decisions to drive better efficiency in clients' strategies. Its clients are hospitals, pharmaceutical, biotech and medical device firms, research institutions, insurance companies, patients, and regulators. It three business segments are: Big Data platform and solutions, which partners with hospitals and policymakers to drive better efficiency; life sciences solutions, which enables better probability of clinical trial success with less drug development time and cost; and health management solutions, which helps with patient management. The Big Data platform accounted for 33% of revenue, life science solutions 30%, and health management solutions 27%, in fiscal 2022.
Executives
Gong Yingying 2202 Interest of your spouse
Xu Jiming 2101 Beneficial owner
Brunei Investment Agency 2101 Beneficial owner
Gic Private Limited 2102 Investment manager
Sweet Panda Limited 2101 Beneficial owner

Yidu Tech (HKSE:02158) Headlines

No Headlines